Axsome Therapeutics target price raised to $249 from $247 by Morgan Stanley
AXSM•Morgan Stanley raised its target price for Axsome Therapeutics to $249 from $247.
Related News
Coinbase Global: KBW cuts target price to $221 from $237
COIN•
Third Coast Bancshares target price cut to $46 from $48
TCBX•
SS&C flags operational challenges as retail access to private markets expands
SSNC•
CommBank forecasts record 14% peak-to-trough fall in Australian home prices
CMWAY•
Cembra completes acquisition of majority of Santander’s Swiss auto financing business
SAN•